98%
921
2 minutes
20
Abnormal passive stiffness of the heart muscle (myocardium) is evident in the pathophysiology of several cardiovascular diseases, making it an important indicator of heart health. Recent advancements in cardiac imaging and biophysical modeling now enable more effective evaluation of this biomarker. Estimating passive myocardial stiffness can be accomplished through an MRI-based approach that requires comprehensive subject-specific input data. This includes the gross cardiac geometry (e.g. from conventional cine imaging), regional diastolic kinematics (e.g. from tagged MRI), microstructural configuration (e.g. from diffusion tensor imaging), and ventricular diastolic pressure, whether invasively measured or non-invasively estimated. Despite the progress in cardiac biomechanics simulations, developing a framework to integrate multiphase and multimodal cardiac MRI data for estimating passive myocardial stiffness has remained a challenge. Moreover, the sensitivity of estimated passive myocardial stiffness to input data has not been fully explored. This study aims to: (1) develop a framework for integrating subject-specific in vivo MRI data into in silico left ventricular finite element models to estimate passive myocardial stiffness, (2) apply the framework to estimate the passive myocardial stiffness of multiple healthy subjects under assumed filling pressure, and (3) assess the sensitivity of these estimates to loading conditions and myofiber orientations. This work contributes toward the establishment of a range of reference values for material parameters of passive myocardium in healthy human subjects. Notably, in this study, beat-to-beat variation in left ventricular end-diastolic pressure was found to have a greater influence on passive myocardial material parameter estimation than variation in fiber orientation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11829060 | PMC |
http://dx.doi.org/10.1038/s41598-025-89243-2 | DOI Listing |
ESC Heart Fail
September 2025
Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Aims: Non-pharmacological therapies for acute decompensated heart failure (HF) and cardiogenic shock have evolved considerably in recent decades. Short-term mechanical circulatory support (MCS) devices can be used as circulatory backup. While nearly all available devices use continuous flow, evidence indicates that pulsatile flow can be more effective.
View Article and Find Full Text PDFLeft ventricular (LV) remodeling, whether occurring as a part of somatic growth or as a chronic response to a sustained stimulus, is a primary factor underlying cardiac mechanical function. Although LV remodeling is a complex process that can be described at several levels (i.e.
View Article and Find Full Text PDFInt J Numer Method Biomed Eng
August 2025
College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, Guangdong, China.
Hypertension-induced alterations in hemodynamics and wave dynamics are important pathological mechanisms for cerebrovascular diseases, vascular cognitive impairment and dementia. However, fundamental understanding of hemodynamics and wave dynamics in hypertension remains limited due to the restricted temporal and spatial resolution of current medical devices. To address the gap, this study developed a closed-loop multiscale computational modeling framework for the entire cardiovascular system.
View Article and Find Full Text PDFiScience
August 2025
School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan Province 610031, China.
Post-resuscitation myocardial dysfunction (PRMD), associated with ferroptosis, contributes significantly to early mortality post-cardiopulmonary resuscitation. However, ferrostatin-1 (Fer-1), a ferroptosis inhibitor, faces challenges in clinical applicability for critical diseases. Here, we report a reactive oxygen species (ROS)-responsive (passively targeting ferroptosis) and myocardium-targeted drug delivery system that facilitates the on-demand delivery of nanoparticles (NPs) encapsulating a ferroptotic inhibitor as tested in a cardiac arrest model.
View Article and Find Full Text PDFJ Clin Med
July 2025
School of Medicine, University of Crete, 70013 Heraklion, Greece.
Chloride, long considered a passive extracellular anion, has emerged as a key determinant in the pathophysiology and management of heart failure (HF) and cardiorenal syndrome. In contrast to sodium, which primarily reflects water balance and vasopressin activity, chloride exerts broader effects on neurohormonal activation, acid-base regulation, renal tubular function, and diuretic responsiveness. Its interaction with With-no-Lysine (WNK) kinases and chloride-sensitive transporters underscores its pivotal role in electrolyte and volume homeostasis.
View Article and Find Full Text PDF